T1	Participants 40 57	dialysis patients
T2	Participants 521 564	654 patients receiving chronic hemodialysis
T3	Participants 1013 1126	Participants had a mean age of 60 Â± 11 years and a median (IQR) FGF23 concentration of 4,212 (1,411-13,816) RU/ml
T4	Participants 1182 1191	lower BMI
T5	Participants 1323 1448	age, gender, race, cardiovascular risk factors, serum albumin, markers of mineral metabolism, and use of lipid-lowering drugs
